Marino Stram & Associates’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $804K | Sell |
1,603
-129
| -7% | -$61.9K | 0.13% | 96 |
|
|
2026
Q1 | $851K | Buy |
1,732
+2
| +0.1% | +$1.08K | 0.15% | 87 |
|
|
2025
Q4 | $1M | Sell |
1,730
-47
| -3% | -$26.6K | 0.18% | 84 |
|
|
2025
Q3 | $862K | Sell |
1,777
-65
| -4% | -$30.3K | 0.16% | 94 |
|
|
2025
Q2 | $747K | Buy |
1,842
+30
| +2% | +$12.5K | 0.15% | 97 |
|
|
2025
Q1 | $901K | Buy |
1,812
+73
| +4% | +$39.5K | 0.2% | 85 |
|
|
2024
Q4 | $905K | Sell |
1,739
-179
| -9% | -$98.4K | 0.2% | 84 |
|
|
2024
Q3 | $1.19M | Buy |
1,918
+14
| +0.7% | +$8.29K | 0.26% | 61 |
|
|
2024
Q2 | $1.05M | Buy |
1,904
+55
| +3% | +$31.5K | 0.26% | 63 |
|
|
2024
Q1 | $1.07M | Hold |
1,849
| – | – | 0.25% | 63 |
|
|
2023
Q4 | $981K | Sell |
1,849
-54
| -3% | -$26.1K | 0.25% | 63 |
|
|
2023
Q3 | $963K | Sell |
1,903
-6
| -0.3% | -$3.2K | 0.28% | 55 |
|
|
2023
Q2 | $996K | Buy |
1,909
+11
| +0.6% | +$5.94K | 0.28% | 57 |
|
|
2023
Q1 | $1.09M | Buy |
1,898
+8
| +0.4% | +$4.51K | 0.33% | 49 |
|
|
2022
Q4 | $1.04M | Buy |
1,890
+28
| +2% | +$14.8K | 0.33% | 49 |
|
|
2022
Q3 | $944K | Buy |
1,862
+57
| +3% | +$31.9K | 0.34% | 50 |
|
|
2022
Q2 | $980K | Buy |
1,805
+40
| +2% | +$22K | 0.34% | 46 |
|
|
2022
Q1 | $1.04M | Buy |
1,765
+56
| +3% | +$32.2K | 0.33% | 48 |
|
|
2021
Q4 | $1.14M | Buy |
1,709
+49
| +3% | +$30.6K | 0.35% | 44 |
|
|
2021
Q3 | $948K | Buy |
1,660
+815
| +96% | +$447K | 0.33% | 49 |
|
|
2021
Q2 | $426K | Sell |
845
-525
| -38% | -$248K | 0.11% | 144 |
|
|
2021
Q1 | $625K | Sell |
1,370
-9
| -0.7% | -$4.3K | 0.24% | 64 |
|
|
2020
Q4 | $642K | Buy |
1,379
+28
| +2% | +$13.1K | 0.29% | 52 |
|
|
2020
Q3 | $596K | Buy |
1,351
+8
| +0.6% | +$3.31K | 0.32% | 53 |
|
|
2020
Q2 | $486K | Buy |
1,343
+218
| +19% | +$73.1K | 0.29% | 58 |
|
|
2020
Q1 | $319K | Buy |
1,125
+399
| +55% | +$126K | 0.25% | 65 |
|
|
2019
Q4 | $236K | Buy |
+726
| New | +$220K | 0.15% | 82 |
|
|
2019
Q2 | – | Sell |
-673
| Closed | -$184K | – | 509 |
|
|
2019
Q1 | $184K | Buy |
673
+34
| +5% | +$8.46K | 0.13% | 81 |
|
|
2018
Q4 | $143K | Buy |
639
+9
| +1% | +$2.11K | 0.12% | 85 |
|
|
2018
Q3 | $154K | Buy |
630
+42
| +7% | +$9.66K | 0.12% | 91 |
|
|
2018
Q2 | $122K | Sell |
588
-5
| -0.8% | -$1.06K | 0.11% | 105 |
|
|
2018
Q1 | $123K | Buy |
593
+87
| +17% | +$18.3K | 0.11% | 102 |
|
|
2017
Q4 | $96K | Buy |
+506
| New | +$96.9K | 0.09% | 119 |
|
Other funds holding TMO
RG
ECSS
LT
Marino Stram & Associates's TMO Position: Q2 2026 in Review
Marino Stram & Associates reduced its Thermo Fisher Scientific (TMO) stake by 7.4% in Q2 2026, selling an estimated $61.9K and leaving 1,603 shares worth $804K. The position accounts for 0.13% of the portfolio, ranked #96.
Marino Stram & Associates first reported a position in TMO in Q4 2017 and has held it in 33 quarters since. The position peaked at $1.19M in Q3 2024. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Marino Stram & Associates held 1,603 shares of Thermo Fisher Scientific worth $804K as of Q2 2026.
- Marino Stram & Associates sold 129 Thermo Fisher Scientific shares in Q2 2026, an estimated $61.9K.
- Thermo Fisher Scientific made up 0.13% of Marino Stram & Associates's portfolio in Q2 2026, its #96 holding.
- Marino Stram & Associates first reported a position in Thermo Fisher Scientific in Q4 2017 and has held it in 33 quarters since.
- Marino Stram & Associates's Thermo Fisher Scientific position peaked at $1.19M in Q3 2024.
- 1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Marino Stram & Associates's 13F filing for Q2 2026, filed 24 Jul 2026.